Corvus Pharmaceuticals Presents Preclinical and Initial Clinical Data from the Phase 1/1b Trial of CPI-818 at the American Society of Hematology (ASH) Annual Meeting

Bud Bilanich
Success Coach

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

David Linetsky
Point-of-Care Marketing

Matthew Durham
Omnidynamic Marketing

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement